Search Results

1 - 2 of 2 items :

  • "quality improvement" x
  • Pharmacology, Toxicology x
Clear All
Developing a diagnostic test to identify the selected mutation within the CFTR gene that determines the onset of cystic fibrosis

REFERENCES 1. Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, et al. Recommendations for quality improvement in genetic testing for cystic fibrosis European Concerted Action on Cystic Fibrosis. Eur J Hum Genet . 2000;8(2):S2-24. 2. Dork T, Macek M, Mekus F, Tümmler B, Tzountzouris J, Casals T, et al. Characterization of a novel 21 - kb delection CFTR dele 2, 3 (21kb) in the CFTR gene: a cystic fibrosis mutation on Slavic orgin in common in Central and East Europe. Hum Genet . 2000;106:259-68. 3. Stężowska-Kubiak S

Open access
Oncoplastic breast surgery techniques - a new look at surgical treatment of breast cancer

. Venous thromboembolism risk in mastectomy and immediate breast reconstruction: analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program data sets. Plast Reconstr Surg. 2014;133(3):263e-273e. 29. Yoon AP, Qi J, Brown DL, Kim HM, Hamill JB, Erdmann-Sager J, et al. Outcomes of immediate versus delayed breast reconstruction: Results of a multicenter prospective study. Breast J. 2018;37:72-9. 30. Fischer JP, Tuggle CT, Au A, Kovach SJ. A 30-day risk assessment of mastectomy alone compared to immediate breast

Open access